We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Could Persistent CD30 Signaling Lead to Blood Cancers?

News   Apr 15, 2019 | Original story from Helmholtz Zentrum München

 
Could Persistent CD30 Signaling Lead to Blood Cancers?

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Early- and Late-Stage Neurodegeneration May Require Bespoke Treatments

News

Rice University biochemists have studied how neurodegeneration kills cells.

READ MORE

Imaging Method Reveals a "Symphony of Cellular Activities"

News

Researchers have now developed a way to image up to five different molecule types at a time, by measuring each signal from random, distinct locations throughout a cell.

READ MORE

Tarantula Toxin Could Help To Design Drugs for Chronic Pain

News

A new high-resolution cryo-electron microscopy study shows how the Chinese tarantula stinger quickly locks voltage sensors on sodium channels, the tiny pores on cell membranes that create electrical currents and generate signals to operate nerves and muscles. This discovery provides a molecular template for future structure-based drug design of pain therapeutics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE